Pharmaceutical Environmental Risk Assessment

Home→ERA Profiles → Bisulepin→

Bisulepin Environmental Risk Assessment (ERA) report

Project-specific environmental risk assessment (ERA) support for human medicinal products and regulatory submissions.

CAS Registry Number
42504-83-6
Molecular formula
C17H19NS2
Molecular weight
301.5 g/mol
Drug class
First-generation tricyclic H1 antihistamineantiallergic agent
Mechanism of action
Antagonises histamine H1 receptors, reducing allergic symptoms such as itching, urticaria and rhinitis. It can produce sedative and anticholinergic effects.
Indications / reported uses
  • Symptomatic treatment of allergic disorders including urticaria, allergic rhinitis and pruritic dermatoses in countries where bisulepin products are authorised; availability is jurisdiction-specific

Sources: NLM MeSH — Bisulepin · PubMed — Bisulepin H1 antihistamine · FDA product information

View request basketPrefer email? info@toxwriter.com
Phase IPhase II where requiredEU / UK / other markets
Assessment scope

Environmental Risk Assessment (ERA)

ToxWriter provides project-specific support for the Bisulepin Environmental Risk Assessment (ERA) (the Bisulepin ERA report). The required pathway is determined by the medicinal product, active-substance form, route, intended market, use assumptions and available environmental evidence.

Assessment may cover

  • Product, active-substance identity, formulation, route and intended-market review.
  • Phase I environmental exposure screening and applicable trigger evaluation.
  • Phase II environmental fate and ecotoxicity assessment where required by the applicable pathway.
  • PEC/PNEC risk characterisation and PBT/vPvB considerations where relevant and supported by evidence.
  • Data-gap analysis, study strategy, assumptions and scientific reporting.
ERA regulatory framework

The EMA guideline sets out the EU framework for environmental risk assessment of human medicinal products. MHRA guidance describes UK expectations; the applicable scope depends on the product and submission context.